Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Journal Article


Authors: Chen, Z.; Trotman, L. C.; Shaffer, D.; Lin, H. K.; Dotan, Z. A.; Niki, M.; Koutcher, J. A.; Scher, H. I.; Ludwig, T.; Gerald, W.; Cordon-Cardo, C.; Pandolfi, P. P.
Article Title: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Abstract: Cellular senescence has been theorized to oppose neoplastic transformation triggered by activation of oncogenic pathways in vitro, but the relevance of senescence in vivo has not been established. The PTEN and p53 tumour suppressors are among the most commonly inactivated or mutated genes in human cancer including prostate cancer. Although they are functionally distinct, reciprocal cooperation has been proposed, as PTEN is thought to regulate p53 stability, and p53 to enhance PTEN transcription. Here we show that conditional inactivation of Trp53 in the mouse prostate fails to produce a tumour phenotype, whereas complete Pten inactivation in the prostate triggers nonlethal invasive prostate cancer after long latency. Strikingly, combined inactivation of Pten and Trp53 elicits invasive prostate cancer as early as 2 weeks after puberty and is invariably lethal by 7 months of age. Importantly, acute Pten inactivation induces growth arrest through the p53-dependent cellular senescence pathway both in vitro and in vivo, which can be fully rescued by combined loss of Trp53. Furthermore, we detected evidence of cellular senescence in specimens from early-stage human prostate cancer. Our results demonstrate the relevance of cellular senescence in restricting tumorigenesis in vivo and support a model for cooperative tumour suppression in which p53 is an essential failsafe protein of Pten-deficient tumours.
Keywords: controlled study; survival analysis; gene mutation; nonhuman; animal cell; mouse; phenotype; animals; mice; gene; cells, cultured; cell cycle; protein stability; genetic transcription; oncology; protein p53; carcinogenesis; cell transformation, neoplastic; prostate cancer; prostatic neoplasms; tumor suppressor gene; prostate; tumors; tumor suppressor proteins; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; pten phosphohydrolase; fibroblasts; tumor suppressor protein p53; gene inactivation; malignant transformation; medicine; cell aging; phosphoric monoester hydrolases; mutagenesis; tryptophan; cells; mitosis inhibition; activation analysis; cellular senescence; trp53 gene; neoplastic transformation; noninvasive medical procedures; regulatory compliance; mutated genes; oncogenic pathways; adp-ribosylation factors
Journal Title: Nature
Volume: 436
Issue: 7051
ISSN: 0028-0836
Publisher: Nature Publishing Group  
Date Published: 2005-08-04
Start Page: 725
End Page: 730
Language: English
DOI: 10.1038/nature03918
PUBMED: 16079851
PROVIDER: scopus
PMCID: PMC1939938
DOI/URL:
Notes: --- - "Cited By (since 1996): 618" - "Export Date: 24 October 2012" - "CODEN: NATUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lloyd Christopher Trotman
    11 Trotman
  2. Zohar A Dotan
    19 Dotan
  3. Zhenbang Chen
    13 Chen
  4. Hui-Kuan Lin
    10 Lin
  5. Masaru Niki
    14 Niki
  6. William L Gerald
    375 Gerald
  7. Jason A Koutcher
    278 Koutcher
  8. Howard Scher
    1129 Scher
  9. David R Shaffer
    25 Shaffer